Skip to main content

Manuel Serrano wins the 48th Leopold Griffuel Award for fundamental cancer research

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

Manuel Serrano, Head of the Cell Plasticity and Senescence lab at IRB Barcelona, has been recognised for his important contributions to the field of cell biology.

Each endowed with €150,000, the Leopold Griffuel Awards are given yearly to two researchers whose exceptional work has accelerated the fight against cancer.

 

On 2 December, Manuel Serrano, ICREA researcher at IRB Barcelona whose laboratory is supported by the "la Caixa" Foundation, received the 48th  Leopold Griffuel Award for fundamental cancer research, granted by the Fondation ARC.

The French foundation has presented him this prize for his important contributions to the field of cell biology and, in particular, to understanding oncogenesis and cellular plasticity.

"I am very honoured and grateful for this recognition. The Fondation ARC carries out very important work because it highlights the relevance of fundamental research, as well as clinical research, in the fight against cancer," says Serrano.

 

Cell plasticity, senescent cells and oncogenesis

Serrano's work is internationally acknowledged and has been the seed of many research projects. Serrano identified and characterised the p16 gene, one of the most important genes in cancer protection. His current studies focus on senescence and cell plasticity and their role in embryonic development, tissue regeneration and anti-oncogenic response.

 

The award in the category of clinical and translational research

In this 48th edition, the Leopold Griffuel Prize in the category of clinical and translational research has been given to Michel Sadelain, at the Memorial Sloan Kettering Cancer Center. Saledain is an immunologist specialising in anti-tumour cell therapy whose work has greatly contributed to the development of CAR-T cells.

 

More information: Fondation ARC

 

 

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to offer pioneering solutions to unresolved medical needs in cancer and other diseases related to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).